METHODS AND SYSTEMS FOR UNIVERSAL CARRIER SCREENING

(19)

(11)

EP 2 288 724 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	17.12.2014 Bulletin 2014/51

(45)	Mention of the grant of the patent:
	12.11.2014 Bulletin 2014/46

(21)	Application number: 09747015.7

(22)	Date of filing: 18.05.2009

(51)

International Patent Classification (IPC):

C12Q 1/68^(2006.01)

G06F 19/18^(2011.01)

(86)	International application number:
	PCT/US2009/003104

(87)	International publication number:
	WO 2009/139929 (19.11.2009 Gazette 2009/47)

(54)	METHODS AND SYSTEMS FOR UNIVERSAL CARRIER SCREENING VERFAHREN UND SYSTEME FÜR UNIVERSELLES TRÄGERSCREENING PROCÉDÉS ET SYSTÈMES POUR UN DÉPISTAGE UNIVERSEL DE PORTEUR

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30)

Priority:

16.05.2008 US 53926 P

(43)	Date of publication of application:
	02.03.2011 Bulletin 2011/09

(73)	Proprietor: Counsyl, Inc.
	South San Francisco, CA 94080 (US)

(72)	Inventors:
	SRINIVASAN, Balaji, S. Palo Alto, CA 94304 (US) SRINIVASAN, Balaji, K. San Francisco, CA 94103 (US) EVANS, Eric Redwood City, CA 94065 (US) SRINIVASAN, Ramji San Francisco, CA 94103 (US) BALAKRISHNAN, Kumaranayagam Staten Island, NY 10301 (US)

(74)	Representative: Kremer, Simon Mark et al
	Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS London EC2V 8AS (GB)

(56)

References cited: :

WO-A2-2007/053752
US-A1- 2003 040 002
US-A1- 2004 210 400
US-A1- 2004 265 849
US-A1- 2006 281 120
US-A1- 2007 050 354
US-A1- 2008 081 331

WO-A2-2007/089145
US-A1- 2003 208 454
US-A1- 2004 229 231
US-A1- 2005 026 117
US-A1- 2007 037 182
US-A1- 2007 111 247

BICK D ET AL: "Screening semen donors for hereditary diseases. The Fairfax cryobank experience.", THE JOURNAL OF REPRODUCTIVE MEDICINE MAY 1998 LNKD- PUBMED:9610465, vol. 43, no. 5, May 1998 (1998-05), pages 423-428, XP009147397, ISSN: 0024-7758
PICCI L ET AL: "Cystic fibrosis as a model for the carrier screening of hereditary genetic diseases", MINERVA BIOTECNOLOGICA 200006 IT, vol. 12, no. 2, June 2000 (2000-06), pages 83-89, XP009147401, ISSN: 1120-4826
MITCHELL J J ET AL: "Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.", AMERICAN JOURNAL OF HUMAN GENETICS OCT 1996 LNKD- PUBMED:8808593, vol. 59, no. 4, October 1996 (1996-10), pages 793-798, XP007918319, ISSN: 0002-9297
TSONGALIS G J ET AL: "Clinical genotyping: The need for interrogation of single nucleotide polymorphisms and mutations in the clinical laboratory", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 363, no. 1-2, 1 January 2006 (2006-01-01), pages 127-137, XP025058622, ISSN: 0009-8981, DOI: DOI:10.1016/J.CCCN.2005.05.043 [retrieved on 2006-01-01]

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).